WILLIAM J DAWSON

CIK 1226139 · Chief Financial Officer · last filed 2026-03-03

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.24M

Companies

3

Total Filings

58

Lifetime Open-Market Net

-$5.10M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
MGRC Director 7,300 $115.09 $840.2K -$5.20M 45 2026-03-03
Adamas Pharmaceuticals Inc (ADMS) Delisted Chief Financial Officer 14,284 $8.22 $117.4K -$12.2K 5 2017-03-22
CERS Chief Financial Officer 156,825 $2.56 $401.5K $108.7K 8 2009-01-14

Recent Filings · Page 2 of 6

58 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-04-05 MGRC Exer (M) +1,700 $0 EDGAR
2021-03-01 MGRC Grant (A) $0 EDGAR
2020-04-02 MGRC Exer (M) +2,000 $0 EDGAR
2020-03-02 MGRC Grant (A) $0 EDGAR
2019-04-02 MGRC Exer (M) +2,200 $0 EDGAR
2019-03-04 MGRC Grant (A) $0 EDGAR
2018-05-07 MGRC Sell (S) −4,843 -$294.2K EDGAR
2018-04-04 MGRC Exer (M) +3,200 $0 EDGAR
2018-03-05 MGRC Grant (A) $0 EDGAR
2017-11-27 MGRC Sell (S) −4,000 -$191.3K EDGAR
Showing 1120 of 58
Page 2 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.